C151 - Lewy Body Dementias
| Event Time: | Tuesday May 7, 2019 3:30 pm to 5:30 pm |
| Topic(s): | Aging, Dementia, Cognitive, and Behavioral Neurology, Advanced Practice Provider |
| Director(s): | Karen Marder MD, MPH, FAAN |
| Description: | Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD), collectively known as Lewy Body Dementias (LBD) are common but difficult to diagnose. Management of concomitant cognitive, motor, behavioral, and autonomic symptoms can be challenging. Cognitive impairment is now recognized as a seminal, often early feature in atypical parkinsonian disorders such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multisystem atrophy (MSA). Comprehensive genetic testing, not yet widely available to the clinician, may identify symptomatic and premanifest individuals who may ultimately benefit from specific targeted treatments. Faculty will use a case-based approach to introduce the clinical features of these disorders and will provide up-to-date recommendations on diagnosis, including interpretion of imaging and genetic testing. Faculty will provide an update on the latest pharmacological and non-pharmacological strategies. |
| Completion Message: | Participants should be able to apply up-to-date clinical criteria and diagnostic tools to diagnose Lewy body dementias and other parkinsonian dementias, understand the value and potential limitations of genetic testing for these disorders, and choose pharmacological and non-pharmacological strategies to treat cognitive, motor, behavioral, and autonomic symptomatology associated with these disorders. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 3:30 PM - 4:00 PM | Lewy Body Dementias (DLB and PDD): New Strategies for Diagnosis and Management | Jennifer G. Goldman MD, MS, FAAN |
| 4:00 PM - 4:10 PM | Questions and Answers | Faculty |
| 4:10 PM - 4:40 PM | Other Parkinsonian Dementias (PSP,CBS, MSA): Advances in Diagnosis and Management | Irene Litvan MD, FAAN |
| 4:40 PM - 4:50 PM | Questions and Answers | Faculty |
| 4:50 PM - 5:20 PM | Genetic Testing for Parkinsonian Dementias: Who, What, Why, and When? | Martha A. Nance MD |
| 5:20 PM - 5:30 PM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Jennifer G. Goldman, MD, MS, FAAN | Dr. Goldman has received personal compensation for consulting, serving on a scientific advisory board, speaking, and other activities with Acadia, Sunovion, and Worldwide Med. Dr. Goldman has received research support from the Michael J. Fox Foundation and the Parkinson's Foundation. |
| Irene Litvan, MD, FAAN | Dr. Litvan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck Advisory Board. Dr. Litvan has received personal compensation in an editorial capacity for the University of California San Diego, Frontiers in Neurology, and Sunovion. Dr. Litvan has received research support from Abbvie, Biogen and Roche. |
| Martha A. Nance, MD | Dr. Nance has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche. Dr. Nance has received research support from Teva Pharmaceuticals and Dong-A ST Co, Ltd. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C165 -
Current Management of Incidental and Asymptomatic Cerebrovascular Lesions
Robert Brown MD, FAAN |
|
C166 -
Neuroimaging Biomarkers Across the Dementia Spectrum
Liana Apostolova MD, FAAN |
|
C167 -
Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome
Ligia Onofrei MD |
|
C168 -
Parkinson's Disease Update
Melissa Nirenberg MD, PhD, FAAN |
|
C169 -
Neurological Intensive Care I: The Essentials
David Greer MD, FAAN |
| 11:30 AM-6:30 PM |
| P4 - |